169
Participants
Start Date
January 31, 2008
Primary Completion Date
March 31, 2011
Study Completion Date
July 31, 2013
Ofatumumab
1000 mL dilution of 35ml of ofatumumab in sterile, pyrogen free 0.9% NaCl. Each treatment cycle consisting of two IV infusion taken 14 days apart. A total of 8 infusion cycles given over a 144 week period
Placebo
1000 mL sterile, pyrogen free 0.9% NaCl. A treatment cycle consisting of two IV infusion taken 14 days apart. Only one placebo treatment cycle provided over a 24 week period
GSK Investigational Site, Rosario
GSK Investigational Site, Lillehammer
GSK Investigational Site, Herlev
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Córdoba
GSK Investigational Site, Trondheim
GSK Investigational Site, Levanger
GSK Investigational Site, Silkeborg
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Potsdam
GSK Investigational Site, Genoa
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Milan
GSK Investigational Site, Varese
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Getafe/Madrid
GSK Investigational Site, Hanover
GSK Investigational Site, Toulouse
GSK Investigational Site, Padua
GSK Investigational Site, Échirolles
GSK Investigational Site, Santander
GSK Investigational Site, Magdeburg
GSK Investigational Site, Seville
GSK Investigational Site, Cahors
GSK Investigational Site, Valencia
GSK Investigational Site, Osnabrück
GSK Investigational Site, Prato
GSK Investigational Site, Strasbourg
GSK Investigational Site, Heidelberg
GSK Investigational Site, Amiens
GSK Investigational Site, Napoli
GSK Investigational Site, Telese Terme (BN)
GSK Investigational Site, Erlangen
GSK Investigational Site, Corbeil-Essonnes
GSK Investigational Site, Ciudad Autónoma de Buenos Aires
GSK Investigational Site, Leipzg
GSK Investigational Site, Rome
GSK Investigational Site, Amsterdam
GSK Investigational Site, Enschede
GSK Investigational Site, Zwolle
GSK Investigational Site, Haugesund
GSK Investigational Site, Lima
GSK Investigational Site, Incheon
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Mérida (Badajoz)
GSK Investigational Site, Oskarström
GSK Investigational Site, Stockholm
GSK Investigational Site, Wishaw
GSK Investigational Site, Newcastle
GSK Investigational Site, Cannock
GSK Investigational Site, Dundee
GSK Investigational Site, Leytonstone, London
Lead Sponsor
GlaxoSmithKline
INDUSTRY